Subscribe to stay informed!
As the pandemic-related business slumps abate, three life sciences companies made long-term commitments to the region. They’ve each signed leases for headquarters…
Malvern-based XyloCor Therapeutics has closed a $41.9 million venture capital funding round, writes John George for the Philadelphia Business Journal.
The gene therapy…
XyloCor Therapeutics, a gene therapy company based in Malvern that is developing new treatments for cardiovascular diseases, has raised $17 million in its series A…
Before we send you to , please subscribe to our daily newsletter.